COVID-19 treatment: Dr Reddy’s partners with Fujifilm, GRA for favipiravir

By: |
July 1, 2020 6:15 PM

Also it grants both Dr Reddy's and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia, a press release from the Indian drug maker said.

The Fujifilm Group is currently conducting a clinical study on Avigan targeting COVID-19 patients in Japan and the US, and is working to increase the drug's production by partnering with domestic and overseas companies.The Fujifilm Group is currently conducting a clinical study on Avigan targeting COVID-19 patients in Japan and the US, and is working to increase the drug’s production by partnering with domestic and overseas companies.

Dr Reddy’s Laboratories on Wednesday announced partnership with Tokyo-based Fujifilm Corporation and Dubai-based Global Response Aid for the development, manufacture and sales of Avigan Tablets (favipiravir), a potential treatment of COVID-19. Under the tripartite agreement, Fujifilm grants Dr Reddy’s the exclusive rights of manufacturing. Also it grants both Dr Reddy’s and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia, a press release from the Indian drug maker said. The company would have exclusive rights for development, selling and distribution of Avigan in India.

Further, Fujifilm would receive an upfront undisclosed license fee and royalties on sales from Dr Reddy’s and GRA, it said. Fujifilm will provide Dr Reddy’s and GRA an array of data on Avigan’s preclinical and clinical studies that it has accumulated so far whilethe latterwill use it for clinical studies targeting COVID-19 in regions where infection has been spreading.

In addition, Fujifilmwill grant Dr Reddy’s right to use Avigan’s patents of formulation and manufacturing method. Dr Reddy’s will herewith establish a setup for manufacturing drugs of the same quality as Avigan, and utilize GRA’s global sales network to supply the manufactured drugs swiftly and in a stable manner.

The Fujifilm Group is currently conducting a clinical study on Avigan targeting COVID-19 patients in Japan and the US, and is working to increase the drug’s production by partnering with domestic and overseas companies. Dr Reddy’s and GRA shall introduce the product in the market post all applicable approvals in the respective countries, it added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1India’s COVID-19 battle: Why is there an outcry for Remdesivir and concerns over the effectiveness of vaccines on the virus
2Political war of words over COVID crisis, supply of medical oxygen to worst affected Maharashtra
3Covid-19 surge: Maharashtra reports over 67,000 new coronavirus cases, highest so far